PRESS RELEASE published on 11/27/2024 at 23:05, 5 months 8 days ago Theralase(R) Release’s 3Q2024 Financial Statements Theralase® Technologies Inc. releases unaudited financial statements for the nine-month period ended September 30, 2024, showcasing key financial and operational results. Conference call scheduled for December 4th Conference Call Financial Statements Operational Results Theralase® Technologies Inc. Study II
BRIEF published on 11/15/2024 at 13:05, 5 months 20 days ago Theralase Technologies conclut un placement privé de 666 400 $CAN Placement Privé Cancer De La Vessie Technologies Théralase Mandats Stade Clinique
BRIEF published on 11/15/2024 at 13:05, 5 months 20 days ago Theralase Technologies Concludes Private Placement of $CAN 666,400 Private Placement Warrants Bladder Cancer Theralase Technologies Clinical Stage
PRESS RELEASE published on 11/15/2024 at 13:00, 5 months 20 days ago Theralase(R) Closes Non-Brokered Private Placement Theralase® Technologies Inc. successfully closes non-brokered private placement offering of units for cancer research and development funding Private Placement Offering Drug Development Clinical Study Cancer Research Theralase® Technologies Inc.
BRIEF published on 11/13/2024 at 00:28, 5 months 23 days ago Theralase Technologies Extends Warrant Expiry to 2027 TSX Venture Exchange Warrant Extension Cancer Treatment Theralase Technologies Pharmaceutical Development
BRIEF published on 11/13/2024 at 00:28, 5 months 23 days ago Theralase Technologies prolonge l'expiration du mandat jusqu'en 2027 Bourse De Croissance TSX Traitement Du Cancer Technologies Théralase Développement Pharmaceutique Prolongation Du Mandat
PRESS RELEASE published on 11/13/2024 at 00:23, 5 months 23 days ago Theralase(R) Extends Warrants Theralase® Technologies Inc. intends to extend the expiry date of 1,000,000 share purchase warrants from Nov 17, 2024, to Nov 17, 2027. This extension is subject to TSXV approval TSX Venture Exchange Expiry Date Extension Theralase Technologies Inc. Share Purchase Warrants Clinical Stage Pharmaceutical Company
BRIEF published on 10/07/2024 at 13:05, 6 months 29 days ago Mises à jour de Theralase sur l'étude clinique sur le cancer de la vessie Approbation De La FDA Étude Clinique Theralase Cancer De La Vessie Ruvidar
BRIEF published on 10/07/2024 at 13:05, 6 months 29 days ago Theralase Updates on Bladder Cancer Clinical Study FDA Approval Clinical Study Theralase Bladder Cancer Ruvidar
PRESS RELEASE published on 10/07/2024 at 13:00, 6 months 29 days ago Theralase(R) Provides Update on Bladder Cancer Clinical Study Theralase® Technologies Inc. provides update on bladder cancer clinical study for BCG-Unresponsive NMIBC CIS using Ruvidar™ drug activated by TLC-3200 Medical Laser System, achieving positive interim results Clinical Study Theralase® Bladder Cancer RuvidarTM BCG-Unresponsive
Published on 05/06/2025 at 08:00, 1 hour 40 minutes ago Pulsar Helium Announces Results of 2025 Annual General and Special Meeting of Shareholders
Published on 05/06/2025 at 01:45, 7 hours 55 minutes ago Forte Group Announces Filing of Fiscal 2024 Audited Financial Statements
Published on 05/06/2025 at 00:20, 9 hours 20 minutes ago McFarlane Lake Announces Listing on the Canadian Securities Exchange (CSE) Effective Thursday, May 8, 2025
Published on 05/05/2025 at 20:00, 13 hours 40 minutes ago PPX Mining Announces Closing of Oversubscribed Private Placement
Published on 05/05/2025 at 15:10, 18 hours 30 minutes ago Star Gold Corp. Refocuses Strategy on Longstreet Project
Published on 05/06/2025 at 09:00, 39 minutes ago Original-Research: Semperit AG Holding (von NuWays AG): BUY
Published on 05/06/2025 at 09:00, 40 minutes ago Singapore Celebrates 60 Years of Independence with an Enticing Multisensory Pavilion ‘RASA-TABULA-SINGAPURA’ at the Venice Architecture Biennale 2025
Published on 05/06/2025 at 08:00, 1 hour 40 minutes ago Ringmetall starts the new year with growth in an increasingly tense market environment
Published on 05/06/2025 at 08:51, 49 minutes ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 avril 2025
Published on 05/06/2025 at 08:30, 1 hour 10 minutes ago Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 28/04/2025 tot 02/05/2025
Published on 05/06/2025 at 08:30, 1 hour 10 minutes ago Cie du Bois Sauvage : Rachat d’actions propres – semaine du 28/04/2025 au 02/05/2025
Published on 05/06/2025 at 08:30, 1 hour 10 minutes ago Cie du Bois Sauvage: Buy back of own shares – week from 28/04/2025 to 02/05/2025
Published on 05/06/2025 at 08:00, 1 hour 40 minutes ago VOGO signe un accord avec l’US Soccer pour le déploiement de ses solutions VOKKERO STAFF et VOKKERO ELITE.
